From: A systematic review of economic evaluations of cervical cancer screening methods
Dominant standalone screening technology | |||
---|---|---|---|
Study | VIA | HPV DNA testing | Cytology |
Legood et al. 2005 [20] | X | Â | Â |
Xie et al. 2017 [33] | X | Â | Â |
Campos et al. 2015 [34] | X | Â | Â |
Lince- Deroche et al. 2015 [35] | X | Â | Â |
Chauhan et al. 2020 [36] | X | Â | Â |
Shi et al. 2011 [37] | Â | X | Â |
Campos et al. 2015 [34] | Â | X | Â |
Sharma et al. 2016 [38] | Â | X | Â |
Kim et al. 2005 [39] | Â | X | Â |
Cromwell et al. 2021 [22] | Â | X | Â |
Termrungruanglert et al. 2017 [40] | Â | X | Â |
Zhao et al. 2019 [41] | Â | X | Â |
Gamboa et al. 2018 [42] | Â | X | Â |
Jansen et al. 2020 [43] | Â | X | Â |
Ma et al. 2019 [44] | Â | X | Â |
Sroczynski et al. 2020 [45] | Â | X | Â |
Goldie et al. 2005 [8] | Â | X | Â |
Campos et al. 2018 [21] | Â | X | Â |
Campos et al. 2012 [46] | Â | X | Â |